Replies to post #445971 on Anavex Life Sciences Corp (AVXL)

[crescentmotor]

I think the worst case is the FDA says run another trial with more subjects.

I think that is exactly the position the FDA will take.

Rett is not dead. It is wounded.

Agree 100%--severe body blow, postponing any future revenues for Rett out for more than three years given the length of the small EXCELLENCE trial.

[Investor2014]

From 99% chance of approval.

Rett is not dead. It is wounded.

To 55%?

Where can I buy one of the probability calculators you are using?

[frrol]

Rett is a long shot with the FDA. For AD, now that we have initiated the EMA application process, let's see what Missling says in the coming weeks re the FDA (and others).